What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1)
Authors
Qaseem, AmirYost, Jennifer
Etxeandia-Ikobaltzeta, Itziar
Forciea, Mary Ann
Abraham, George M
Miller, Matthew C.
Obley, Adam J.
Humphrey, Linda L.
UMass Chan Affiliations
Department of MedicineDocument Type
Journal ArticlePublication Date
2021-03-16Keywords
Preventionpolicy
and public health
Antibody production
Immunity
COVID-19
Treatment guidelines
Immunology and Infectious Disease
Infectious Disease
Medical Immunology
Microbiology
Virus Diseases
Metadata
Show full item recordAbstract
Description: The widespread availability of SARS-CoV-2 antibody tests raises important questions for clinicians, patients, and public health professionals related to the appropriate use and interpretation of these tests. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians developed these rapid, living practice points to summarize the current and best available evidence on the antibody response to SARS-CoV-2 infection, antibody durability after initial infection with SARS-CoV-2, and antibody protection against reinfection with SARS-CoV-2. Methods: The SMPC developed these rapid, living practice points based on a rapid and living systematic evidence review done by the Portland VA Research Foundation and funded by the Agency for Healthcare Research and Quality. Ongoing literature surveillance is planned through December 2021. When new studies are identified and a full update of the evidence review is published, the SMPC will assess the new evidence and any effect on the practice points. Practice Points: Practice Point 1: Do not use SARS-CoV-2 antibody tests for the diagnosis of SARS-CoV-2 infection. Practice Point 2: Antibody tests can be useful for the purpose of estimating community prevalence of SARS-CoV-2 infection. Practice Point 3: Current evidence is uncertain to predict presence, level, or durability of natural immunity conferred by SARS-CoV-2 antibodies against reinfection (after SARS-CoV-2 infection).Source
Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller MC, Obley AJ, Humphrey LL. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 Mar 16. doi: 10.7326/M20-7569. Epub ahead of print. PMID: 33721518. Link to article on publisher's site
DOI
10.7326/M20-7569Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27390PubMed ID
33721518Related Resources
ae974a485f413a2113503eed53cd6c53
10.7326/M20-7569